PD13-04 PROSTATE CANCER SPECIFIC MORTALITY IN THE ERSPC TRIAL: WHAT IS THE ROLE OF SCREENING RESULT AND ADHERENCE

Christian Wetterauer,Sebastiaan Remmers,Lukas Prause,Jonas Hugosson,Teuvo L.J. Tammela,Marco Zappa,Vera Nelen,Marcos Luján,Louis Denis,Álvaro Páez,Donella Puliti,Arnauld Villers,Xavier Rebillard,Rebecka Arnsrud Godtman,Chris H. Bangma,Fritz H. Schröder,Anssi Auvinen,Lukas Manka,Helge Seifert,Stephen Wyler,Monique J. Roobol,Maciej Kwiatkowski

PD13-04 PROSTATE CANCER SPECIFIC MORTALITY IN THE ERSPC TRIAL: WHAT IS THE ROLE OF SCREENING RESULT AND ADHERENCE

2021

INTRODUCTION AND OBJECTIVE:With a median follow–up of 16 years the European Randomized Study of Screening for Prostate Cancer (ERSPC) shows a relative reduction of prostate cancer (PCa) specific mo...

Keywords:

Screening Result
specific mortality
Oncology
Randomized controlled trial
Internal medicine
Prostate cancer
Medicine

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations